Process for the preparation of a benzazepine derivative
WO2012137216A1
A novel pharmaceutical formulation of alpha ketoanalogue of amino acids and additional amino acids for treatment of chronic kidney disease and method of preparation thereof
WO2011125069A1
A process for preparation of crystalline form i of clopidogrel bisulfate
EP1902058A2
A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
WO2007017890A2
Process for preparation of pantoprazole sodium sesquihydrate and product prepared therby
WO2005109990A2
Mouth dissolvable and meltable, and water dispersable delivery formulation
ZA200301928B
Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities.
AU2001225459C1
Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
WO0218357A1
A ONE-POT PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 4, 5, 6, 7 - TETRAHYDROTHIENO (3,2-c) PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY
WO0185731A1
A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one
BR0016980A
A process for the preparation of 6- (2-3, -dichlorophenyl) -1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
GB0214791D0
A process for the preparation of 6-(2,3-Dichlorophenyl)-1,2,4- Triazine-3,5-Diamine, commonly known as Lamotrigine
AU4609100A
Preparation of 2-(4-ethoxyphenyl)-2-methylpropyl alcohol
